BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30520487)

  • 1. Enhanced intrinsic CYP3A4 activity in human hepatic C3A cells with optically controlled CRISPR/dCas9 activator complex.
    Han S; Wei S; Wang X; Han X; Zhang M; Su M; Li Y; Guo J; Zeng W; Liu J; Gao Y; Shen L
    Integr Biol (Camb); 2018 Dec; 10(12):780-790. PubMed ID: 30520487
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang W; Zhao H; Dou Y; Wang P; Chang Q; Qiao X; Wang X; Xu C; Zhang Z; Zhang L
    Drug Metab Dispos; 2023 Apr; 51(4):492-498. PubMed ID: 36623883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene activation by a CRISPR-assisted
    Xu X; Gao J; Dai W; Wang D; Wu J; Wang J
    Elife; 2019 Apr; 8():. PubMed ID: 30973327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems.
    Lowder LG; Zhou J; Zhang Y; Malzahn A; Zhong Z; Hsieh TF; Voytas DF; Zhang Y; Qi Y
    Mol Plant; 2018 Feb; 11(2):245-256. PubMed ID: 29197638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Free Estrogen Receptor
    Wang D; Lu R; Rempala G; Sadee W
    Mol Pharmacol; 2019 Oct; 96(4):430-440. PubMed ID: 31399483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.
    Luo N; Zhong W; Li J; Lu J; Dong R
    Mol Biol Rep; 2022 Dec; 49(12):11403-11408. PubMed ID: 35960410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.
    Luo N; Li J; Chen Y; Xu Y; Wei Y; Lu J; Dong R
    Drug Deliv; 2021 Dec; 28(1):10-18. PubMed ID: 33336604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
    Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
    Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic activation of cardiosphere-derived cells enhances myocardial repair.
    Sano T; Ito T; Ishigami S; Bandaru S; Sano S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1479-1490.e5. PubMed ID: 32682583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a CRISPR-Based System for Gene Regulation in
    Román E; Coman I; Prieto D; Alonso-Monge R; Pla J
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-acting regulatory elements regulating CYP3A4 transcription in human liver.
    Collins JM; Wang D
    Pharmacogenet Genomics; 2020 Jul; 30(5):107-116. PubMed ID: 32301865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.
    Liu Y; Flynn TJ; Xia M; Wiesenfeld PL; Ferguson MS
    Cell Biol Toxicol; 2015 Oct; 31(4-5):221-30. PubMed ID: 26377104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex.
    He M; Zhou X; Li Z; Yin X; Han W; Zhou J; Sun X; Liu X; Yao D; Liang H
    J Am Chem Soc; 2022 Jul; 144(28):12690-12697. PubMed ID: 35792375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application.
    Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R
    Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
    Park JJ; Dempewolf E; Zhang W; Wang ZY
    PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae.
    Deaner M; Mejia J; Alper HS
    ACS Synth Biol; 2017 Oct; 6(10):1931-1943. PubMed ID: 28700213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.